These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 11034370)

  • 41. Differential role of Fas/Fas ligand interactions in cytolysis of primary and metastatic colon carcinoma cell lines by human antigen-specific CD8+ CTL.
    Bergmann-Leitner ES; Abrams SI
    J Immunol; 2000 May; 164(9):4941-54. PubMed ID: 10779805
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Inhibition of CTL induction by rapamycin: IL-2 rescues granzyme B and perforin expression but only partially restores cytotoxic activity.
    Makrigiannis AP; Hoskin DW
    J Immunol; 1997 Nov; 159(10):4700-7. PubMed ID: 9366393
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Functional defects of NK cells treated with chloroquine mimic the lytic defects observed in perforin-deficient mice.
    Austin Taylor M; Bennett M; Kumar V; Schatzle JD
    J Immunol; 2000 Nov; 165(9):5048-53. PubMed ID: 11046034
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Perforin-deficient CD8+ T cells provide immunity to Listeria monocytogenes by a mechanism that is independent of CD95 and IFN-gamma but requires TNF-alpha.
    White DW; Harty JT
    J Immunol; 1998 Jan; 160(2):898-905. PubMed ID: 9551927
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antigen-induced cell death of T effector cells in vitro proceeds via the Fas pathway, requires endogenous interferon-gamma and is independent of perforin and granzymes.
    Sobek V; Balkow S; Körner H; Simon MM
    Eur J Immunol; 2002 Sep; 32(9):2490-9. PubMed ID: 12207333
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Fas-independent cytotoxicity mediated by human CD4+ CTL directed against herpes simplex virus-infected cells.
    Yasukawa M; Ohminami H; Yakushijin Y; Arai J; Hasegawa A; Ishida Y; Fujita S
    J Immunol; 1999 May; 162(10):6100-6. PubMed ID: 10229852
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Granzyme C supports efficient CTL-mediated killing late in primary alloimmune responses.
    Getachew Y; Stout-Delgado H; Miller BC; Thiele DL
    J Immunol; 2008 Dec; 181(11):7810-7. PubMed ID: 19017970
    [TBL] [Abstract][Full Text] [Related]  

  • 48. CD95 ligand-expressing tumors are rejected in anti-tumor TCR transgenic perforin knockout mice.
    Behrens CK; Igney FH; Arnold B; Möller P; Krammer PH
    J Immunol; 2001 Mar; 166(5):3240-7. PubMed ID: 11207278
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Regulation of Fas(Apo-1/CD95)- and perforin-mediated lytic pathways of primary cytotoxic T lymphocytes by the protooncogene bcl-2.
    Schröter M; Lowin B; Borner C; Tschopp J
    Eur J Immunol; 1995 Dec; 25(12):3509-13. PubMed ID: 8566045
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Concerted action of the FasL/Fas and perforin/granzyme A and B pathways is mandatory for the development of early viral hepatitis but not for recovery from viral infection.
    Balkow S; Kersten A; Tran TT; Stehle T; Grosse P; Museteanu C; Utermöhlen O; Pircher H; von Weizsäcker F; Wallich R; Müllbacher A; Simon MM
    J Virol; 2001 Sep; 75(18):8781-91. PubMed ID: 11507223
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Tumor immunity in perforin-deficient mice: a role for CD95 (Fas/APO-1).
    Rosen D; Li JH; Keidar S; Markon I; Orda R; Berke G
    J Immunol; 2000 Mar; 164(6):3229-35. PubMed ID: 10706715
    [TBL] [Abstract][Full Text] [Related]  

  • 52. How do cytotoxic lymphocytes kill their targets?
    Shresta S; Pham CT; Thomas DA; Graubert TA; Ley TJ
    Curr Opin Immunol; 1998 Oct; 10(5):581-7. PubMed ID: 9794837
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of perforin, granzymes and the proliferative state of the target cells in apoptosis and necrosis mediated by bispecific-antibody-activated cytotoxic T cells.
    Renner C; Held G; Ohnesorge S; Bauer S; Gerlach K; Pfitzenmeier JP; Pfreundschuh M
    Cancer Immunol Immunother; 1997 Apr; 44(2):70-6. PubMed ID: 9177467
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Perforin and Fas act together in the induction of apoptosis, and both are critical in the clearance of lymphocytic choriomeningitis virus infection.
    Rode M; Balkow S; Sobek V; Brehm R; Martin P; Kersten A; Dumrese T; Stehle T; Müllbacher A; Wallich R; Simon MM
    J Virol; 2004 Nov; 78(22):12395-405. PubMed ID: 15507626
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of the Fas ligand/Fas-dependent apoptosis of antiretroviral, class I MHC tetramer-defined, CD8+ CTL by in vivo retrovirus-infected cells.
    Rich RF; Green WR
    J Immunol; 2002 Mar; 168(6):2751-8. PubMed ID: 11884442
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Differential antitumor effects of administration of recombinant IL-18 or recombinant IL-12 are mediated primarily by Fas-Fas ligand- and perforin-induced tumor apoptosis, respectively.
    Hashimoto W; Osaki T; Okamura H; Robbins PD; Kurimoto M; Nagata S; Lotze MT; Tahara H
    J Immunol; 1999 Jul; 163(2):583-9. PubMed ID: 10395644
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Two types of anti-TL (thymus leukemia) CTL clones with distinct target specificities: differences in cytotoxic mechanisms and accessory molecule requirements.
    Tsujimura K; Takahashi T; Iwase S; Matsudaira Y; Kaneko Y; Yagita H; Obata Y
    J Immunol; 1998 Jun; 160(11):5253-61. PubMed ID: 9605121
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Redirected perforin-dependent lysis of colon carcinoma by ex vivo genetically engineered CTL.
    Darcy PK; Haynes NM; Snook MB; Trapani JA; Cerruti L; Jane SM; Smyth MJ
    J Immunol; 2000 Apr; 164(7):3705-12. PubMed ID: 10725729
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cell-mediated cytotoxic mechanisms.
    Squier MK; Cohen JJ
    Curr Opin Immunol; 1994 Jun; 6(3):447-52. PubMed ID: 7522467
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Molecular mechanisms of immune-mediated lysis of murine renal cancer: differential contributions of perforin-dependent versus Fas-mediated pathways in lysis by NK and T cells.
    Sayers TJ; Brooks AD; Lee JK; Fenton RG; Komschlies KL; Wigginton JM; Winkler-Pickett R; Wiltrout RH
    J Immunol; 1998 Oct; 161(8):3957-65. PubMed ID: 9780164
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.